Medicine makers end the week on a high note at Dalal Street
Advertisement
Advertisement
Shares of medicine makers were mostly higher in weak trade on Friday as investors sought the safety of predictable revenue and profit streams coupled with the potential of higher-than-expected sales following the depreciation in the The Rupee fell to a fresh 2-year low versus the Dollar as a global turmoil in currencies and
As a result, 6 out of 11 pharma stock futures posted gains with rising open interest and four pharma companies hit fresh highs in an overall market that has slumped to 2-month lows.
Strides Arcolabs gained 1.8 percent to 1,343 rupees. Divi's Labs was up 1.4 percent to 2,435 rupees. Auro Pharma rose 1.6 percent to 810 rupees. Glenmark Pharma was up 13 percent to 1,231 rupees. Cipla rose 0.7 percent to 697.30 rupees. and
Torrent Pharma and Sanofi India were the other stocks that rose in the drugs space.
Advertisement
(Image credits: Indiatimes)
Advertisement
- I got a $40K raise using this 30-second strategy. It made me realize loud work, not hard work, always wins.
- Qatar Airways' new CEO explains why it's sticking with the Airbus A380 as other airlines retire the costly superjumbo
- Prince Harry and Meghan found out about Kate Middleton's cancer diagnosis on TV like everyone else, report says
- PM Modi and Bill Gates discuss AI, climate change, millets and more
- Consuming excessive salt and inadequate potassium, protein is making North Indians prone to life-threatening diseases: Study
- Upcoming cars and two-wheelers launching in India in April 2024
- Ice melt in Antarctica and Greenland is slowing Earth's rotation, affecting timekeeping: Study
- Elections on a plate: Poll panels fix menu & expense ceiling for Samosa, tea, biryani & more